Alliqua BioMedical
Yardley, US · Delaware corporation
Founders & leadership
BP
Brian PosnerChief Financial Officer, Treasurer and Secretary
DJ
David JohnsonExecutive
PP
Pellegrino PionatiChief Strategy and Marketing Officer
BB
Brad BartonChief Operating Officer
SC
Steven C. BergerChief Financial Officer of the Issuer
RR
Richard RosenblumPresident and Director of the Issuer
Board
MG
Michael GoldbergBoard director
DS
David StefanskyChairman of the Issuer
JZ
Jerome ZeldisBoard director
JL
Joseph LeoneBoard director
GR
Gary RestaniBoard director
JS
Jeffrey SklarBoard director
Reported raises · per SEC filings
Form D private placements$20.8M disclosed across 4 rounds · 2012–2017
▶$2.8MraisedMar 2017 · 8 investors · BiotechnologyRule 506(b)
▶$2.8MraisedMar 2017 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian PosnerExecutive Officer
- Jerome ZeldisDirector
- David JohnsonExecutive Officer, Director
- Pellegrino PionatiExecutive Officer
- Joseph LeoneDirector
- Gary RestaniDirector
- Jeffrey SklarDirector
- Brad BartonExecutive Officer
- Winston KungDirector
- Mark WagnerDirector
- Offering amount
- $2.9M
- Amount sold
- $2.8M
- Sales commissions
- $196.2K
- Placement agents
- Cova Capital Partners, LLC, H.C. Wainwright & Co., LLC
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedMay 2014 · 43 investors · BiotechnologyRule 506(b)
▶$2MraisedMay 2014 · 43 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kenneth PearsenDirector
- Brian PosnerExecutive Officer
- Perry KarsenDirector
- Jerome ZeldisDirector
- Jeffrey SklarDirector
- David StefanskyDirector
- Joseph LeoneDirector
- David JohnsonExecutive Officer, Director
- Offering amount
- $7M
- Amount sold
- $2M
- First sale
- May 2014
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
▶$15MraisedApr 2014 · 18 investors · BiotechnologyRule 506(b)
▶$15MraisedApr 2014 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph LeoneDirector
- Kenneth PearsenDirector
- David JohnsonExecutive Officer, Director
- Perry KarsenDirector
- Brian PosnerExecutive Officer
- Jeffrey SklarDirector
- David StefanskyDirector
- Jerome ZeldisDirector
- Offering amount
- $15M
- Amount sold
- $15M
- Sales commissions
- $598.5K
- Placement agents
- Summer Street Research Partners
- First sale
- Apr 2014
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
▶$1.1MraisedMar 2012 · 12 investors · BiotechnologyRule 506(b)
▶$1.1MraisedMar 2012 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph SierchioDirector
- Joseph M. LeoneDirector
- Jeffrey SklarDirector
- Steven C. BergerExecutive Officer
- Michael GoldbergDirector
- Kenneth PearsenDirector
- David StefanskyDirector
- Richard RosenblumExecutive Officer, Director
- Nochum SteinDirector
- Offering amount
- $1.1M
- Amount sold
- $1.1M
- Sales commissions
- $55.5K
- Placement agents
- Palladium Capital Advisors, LLC
- First sale
- Feb 2012
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Alliqua BioMedical raised?
- Alliqua BioMedical has disclosed $20.8M raised across 4 rounds.
- Where is Alliqua BioMedical headquartered?
- Alliqua BioMedical is headquartered in Yardley, US.